send to a friend by email

JPH posts net income of $5.06 million in 2024

2025-02-11

According to the financial statements of Jerusalem Pharmaceuticals JPH for the year 2024, Net profit after tax of the period reached 5,063,506 USD Compared with Net profit after tax 7,008,081 USD for 2023, a net decrease in profit of 27.75%.Total assets of the company reached 89,339,325 USD compared with total assets of 86,320,946 USD at the end of year 2023, a net increase of 3.50%.Total liabilities of the company reached 18,064,321 USD compared with total liabilities of 17,442,878 USD at the end of year 2023, a net increase of 3.56%. Net ownership equity of the company reached 71,275,004 USD (Including Non-Controlling Interests of 978,424 USD) compared with total owner equity of 68,878,068 USD (Including Non-Controlling Interests of 1,037,498 USD) at the end of year 2023, a net increase of 3.48%.